Recent basic experiments have strongly suggested that
cell transplantation therapy may promote functional recovery in patients with
spinal cord injury (SCI). However, a safe and efficient
transplantation technique still remains undetermined. This study, therefore, was aimed to clarify whether
fibrin matrix could be a useful scaffold in bone marrow stromal cell (BMSC)
transplantation for the injured spinal cord. To clarify the issue, three-dimensional structure of
fibrin matrix was assessed and the
green fluorescent protein (GFP)-expressing BMSC were cultured in
fibrin matrix. The rats were subjected to spinal cord hemisection at T8 level, and the vehicle, BMSC or BMSC-
fibrin matrix construct was implanted into the cavity. Neurologic function was serially evaluated. Using immunohistochemistry, we evaluated the survival, migration and differentiation of the transplanted cells at 4 weeks after
transplantation. In the initial in vitro study, the BMSC could survive in
fibrin matrix for 2 weeks. The animals treated with the BMSC-
fibrin matrix construct showed significantly more pronounced recovery of neurologic function than vehicle- or BMSC-treated animals.
Fibrin scaffold markedly improved the survival and migration of the transplanted cells. There was no significant difference in the percentage of cells doubly positive for GFP and
microtubule-associated protein 2 between the animals treated with BMSC-
fibrin matrix construct and those treated with BMSC, but a certain subpopulation of GFP-positive cells morphologically simulated the neurons in the animals treated with BMSC-
fibrin matrix construct. These findings strongly suggest that
fibrin matrix may be one of the promising candidates for a potential, minimally invasive scaffold for injured spinal cord, and that such strategy of tissue engineering could be a hopeful option in regeneration
therapy for patients with SCI.